Related Experiment Videos
New fluorinated erythromycins obtained by mutasynthesis.
The Journal of Antibiotics
|November 1, 1983
Summary
Researchers created novel fluoroerythromycin antibiotics using mutational biosynthesis. This method successfully produced four new fluoroerythromycin compounds with promising biological properties.
Area of Science:
- Microbiology
- Biochemistry
- Medicinal Chemistry
Background:
- Semisynthetic preparation of novel aglycones, including (8S)-8-fluoroerythronolide A and B, and their monoglycoside derivative.
- Utilized a mutant strain of Streptomyces erythraeus (ATCC 31772) deficient in erythromycin biosynthesis.
Purpose of the Study:
- To convert previously synthesized fluoroerythronolide aglycones into new fluoroerythromycin antibiotics.
- To investigate the potential of mutational biosynthesis for generating novel antibiotic structures.
Main Methods:
- Employing mutational biosynthesis using Streptomyces erythraeus ATCC 31772.
- Utilizing semisynthetically prepared aglycones as precursors for antibiotic synthesis.
Main Results:
- Successfully derived four new fluoroerythromycin antibiotics: (8S)-8-fluoroerythromycin A, B, C, and D.
- Demonstrated the successful conversion of fluoroerythronolide precursors into novel fluoroerythromycins.
- Observed promising biological properties in the newly synthesized antibiotics.
Conclusions:
- Mutational biosynthesis is an effective strategy for producing novel fluoroerythromycin derivatives.
- The study provides insights into the substrate specificity of enzymes involved in erythromycin biosynthesis.
- The newly developed fluoroerythromycins hold potential for future therapeutic applications.